French Startup CorWave Sets Global Milestone with Breakthrough Heart Pump Implant, Bringing New Hope to Heart Failure Patients
Paris, France – July 9, 2025 – In a major stride for medical science, French President Emmanuel Macron has announced a historic achievement by French med-tech startup CorWave, which has successfully performed the first-ever implantation of a pioneering heart pump. This landmark moment offers renewed optimism for millions affected by chronic heart failure across the world.
President Macron shared the news through social media, applauding the team behind the innovation: “CorWave has accomplished a world first with this unique heart pump implantation. A significant leap forward for those living with heart failure. Well done to the entire team – your work is truly commendable.”
Although exact clinical details and the identity of the recipient remain undisclosed, the term “unique” suggests a major advancement over existing ventricular assist devices (VADs). Heart failure, a life-limiting condition in which the heart cannot efficiently pump blood, affects millions globally and often leaves patients reliant on limited treatment options such as medications or heart transplants.
CorWave is known for its cutting-edge wave membrane pump technology, engineered to replicate the heart’s natural pulsatile motion—unlike conventional rotary pumps that offer continuous flow. If the recent procedure marks the clinical application of this technology, it may redefine the future of mechanical heart support with a more physiological, longer-lasting solution.
This medical breakthrough highlights not only France’s rising prominence in biotech innovation but also signals a transformative step in cardiology. With this development, patients suffering from advanced heart failure may soon have access to safer, more effective treatment, improving both survival and quality of life. It is a monumental moment for healthcare, patients, and the global medical community alike.
